Scarica l'app Stockscreener
620.59
0.56%
3.44
Precedente Chiudi:
$617.15
Aprire:
$612.3
Volume 24 ore:
303.08K
Relative Volume:
1.05
Capitalizzazione di mercato:
$17.32B
Reddito:
$2.68B
Utile/perdita netta:
$460.40M
Rapporto P/E:
39.04
EPS:
15.8963
Flusso di cassa netto:
$711.00M
1 W Prestazione:
+0.88%
1M Prestazione:
+0.09%
6M Prestazione:
+34.69%
1 anno Prestazione:
+24.79%
Intervallo 1D:
$610.79
$626.83
Intervallo di 1 settimana:
$608.54
$637.64
Portata 52W:
$373.00
$677.90
Medpace Holdings Inc Stock (MEDP) Company Profile
Nome
Medpace Holdings Inc
Settore
Industria
Telefono
(513) 579-9911
Indirizzo
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
620.59 | 17.32B | 2.68B | 460.40M | 711.00M | 15.90 |
TMO
Thermo Fisher Scientific Inc
|
678.39 | 250.83B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
223.77 | 157.31B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
408.79 | 58.92B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.84 | 48.73B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
275.02 | 45.27B | 16.63B | 1.39B | 2.12B | 8.0674 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2026-03-03 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-02-18 | Aggiornamento | TD Cowen | Sell → Hold |
| 2026-02-13 | Aggiornamento | Jefferies | Hold → Buy |
| 2026-02-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-02 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-09-03 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-29 | Downgrade | UBS | Neutral → Sell |
| 2025-07-23 | Downgrade | TD Cowen | Hold → Sell |
| 2025-06-24 | Iniziato | Barclays | Equal Weight |
| 2025-04-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-24 | Iniziato | Leerink Partners | Market Perform |
| 2024-10-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-27 | Downgrade | UBS | Buy → Neutral |
| 2024-09-25 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-01 | Iniziato | Truist | Hold |
| 2024-05-29 | Iniziato | TD Cowen | Buy |
| 2024-05-28 | Iniziato | Mizuho | Buy |
| 2024-04-23 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-18 | Iniziato | Deutsche Bank | Hold |
| 2024-02-15 | Aggiornamento | UBS | Neutral → Buy |
| 2023-10-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-10-27 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-07 | Iniziato | UBS | Sell |
| 2022-05-24 | Iniziato | Guggenheim | Neutral |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-10-02 | Aggiornamento | Truist | Hold → Buy |
| 2020-06-08 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Aggiornamento | SunTrust | Sell → Hold |
| 2020-04-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Downgrade | SunTrust | Hold → Sell |
| 2020-01-27 | Downgrade | SunTrust | Buy → Hold |
| 2018-10-31 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-09-17 | Iniziato | SunTrust | Hold |
| 2018-07-31 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Iniziato | Raymond James | Mkt Perform |
| 2017-07-10 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Mostra tutto
Medpace Holdings Inc Borsa (MEDP) Ultime notizie
Insider Transaction: August J Troendle Sells $44.43M Worth Of Medpace Holdings Shares - Benzinga
Medpace Holdings, Inc. (MEDP) Stock Forecasts - Yahoo! Finance Canada
Have Insiders Sold Medpace Holdings Shares Recently? - simplywall.st
Medpace stock falls 2.07 percent as CEO sale surfaces - AD HOC NEWS
Medpace (MEDP) CEO sold 49,018 shares on Sept. 22 at a $628.11 average price. - Stock Titan
MEDP FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile
Medpace Holdings, Inc. (MEDP) Stock forecasts - Yahoo Finance UK
Mizuho maintains Outperform on Medpace, raises target to $586 - scanx.trade
Medpace Holdings Q3FY26 Results: Earnings call set for Oct 22 - scanx.trade
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026 - Business Wire
Medpace Holdings President & CEO Trades $6.75M In Company Stock - Benzinga
Medpace Holdings (MEDP) Nears Earnings, Is The Stock Fully Valued? - finance.yahoo.com
Medpace Holdings Insider Sold Shares Worth $6,749,952, According to a Recent SEC Filing - Moomoo
Medpace (MEDP) Outperforms Broader Market: What You Need to Know - finance.yahoo.com
Medpace (NASDAQ:MEDP) CEO Sells $6,749,952.00 in Stock - MarketBeat
Medpace (NASDAQ: MEDP) CEO sells shares, holds 504,273 directly - Stock Titan
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Medpace Holdings, Inc.Common Stock (Nasdaq:MEDP) Price Chart - The Chronicle-Journal
Medpace Holdings President & CEO Sold $15.36M In Company Stock - Benzinga
Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Connect - accessnewswire.com
Medpace Holdings (MEDP) CEO sells stock in two $620-range trades - Stock Titan
Medpace Holdings (MEDP) insider exercises 3,000 options - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
Medpace (MEDP) Retreats -0.57%, Breaching $586.11 Support Line 2026-09-16Bearish Sentiment - careplusvn.com
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP), Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Medpace Holdings Inc (MEDP) Stock Up 4.1% but GF Value Says Over - GuruFocus
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Medpace Holdings, Inc. (MEDP) Stock Analysis: A Resilient Growth Story With A Strong ROE - DirectorsTalk Interviews
Jefferies reiterates Medpace stock rating at Hold with $560 target - Investing.com
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years - Benzinga
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Reach Out - ACCESS Newswire
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Medpace Holdings, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsMEDP - Eastern Progress
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After President Allegedly Oversaw Misleading Disclosures: Levi & Korsinsky - Eastern Progress
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Eastern Progress
Medpace Deadline: MEDP Investors with Losses in Excess of $100K Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit - easternprogress.com
Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential - DirectorsTalk Interviews
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming DeadlinesMEDP - Eastern Progress
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Medpace Holdings Inc. (MEDP) Key Financial Ratios – Valuation, Profitability & More - Value Research
Medpace Holdings, Inc. (MEDP), Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Medpace Holdings, Inc. (MEDP), Investigation: Bronstein, Gewirtz - The National Law Review
President & CEO Of Medpace Holdings Makes $403K Sale - benzinga.com
Why Medpace (MEDP) is a Top Growth Stock for the Long-Term - Eastern Progress
Medpace Holdings Inc. (MEDP) Peer Comparison – Compare with Others - valueresearchonline.com
Medpace Holdings Insider Sold Shares Worth $403,176, According to a Recent SEC Filing - marketscreener.com
Medpace Holdings (MEDP) CEO sells 650 shares near $620 - Stock Titan
Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Its Robust Revenue Growth and Market Position - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Medpace Holdings (MEDP) director exercises options, sells 3,858 shares - Stock Titan
President & CEO At Medpace Holdings Sells $2.90M Of Stock - Benzinga
Medpace Holdings Inc Azioni (MEDP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.54%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):